Balaji Amines Ltd
Incorporate in 1989, Balaji Amines Ltd is engaged in manufacturing of specialty chemicals, aliphatic amines, and derivatives, along with ownership of a five-star hotel in Solapur, Maharashtra.[1]
- Market Cap ₹ 6,907 Cr.
- Current Price ₹ 2,132
- High / Low ₹ 2,630 / 905
- Stock P/E 33.8
- Book Value ₹ 610
- Dividend Yield 0.51 %
- ROCE 11.0 %
- ROE 8.74 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 20.4%
- Company's working capital requirements have reduced from 101 days to 68.8 days
Cons
- Stock is trading at 3.51 times its book value
- The company has delivered a poor sales growth of 1.64% over past five years.
- Company has a low return on equity of 9.92% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 616 | 640 | 668 | 858 | 940 | 935 | 1,308 | 2,314 | 2,346 | 1,631 | 1,389 | 1,419 | 1,523 | |
| 515 | 514 | 519 | 676 | 747 | 754 | 935 | 1,691 | 1,736 | 1,308 | 1,157 | 1,154 | 1,196 | |
| Operating Profit | 102 | 127 | 149 | 182 | 193 | 181 | 373 | 623 | 609 | 324 | 232 | 265 | 327 |
| OPM % | 17% | 20% | 22% | 21% | 21% | 19% | 29% | 27% | 26% | 20% | 17% | 19% | 21% |
| 4 | 3 | 9 | 12 | 4 | 5 | 6 | 15 | 15 | 30 | 33 | 29 | 25 | |
| Interest | 35 | 22 | 13 | 9 | 13 | 23 | 18 | 17 | 12 | 6 | 4 | 5 | 6 |
| Depreciation | 20 | 19 | 20 | 19 | 20 | 32 | 34 | 42 | 46 | 45 | 48 | 56 | 56 |
| Profit before tax | 51 | 88 | 126 | 166 | 165 | 131 | 327 | 578 | 567 | 302 | 213 | 232 | 290 |
| Tax % | 35% | 34% | 34% | 32% | 29% | 26% | 25% | 28% | 28% | 23% | 26% | 27% | |
| 33 | 58 | 82 | 113 | 117 | 97 | 243 | 418 | 406 | 232 | 159 | 169 | 211 | |
| EPS in Rs | 10.25 | 17.78 | 25.42 | 34.93 | 36.27 | 32.34 | 73.51 | 113.71 | 100.47 | 63.22 | 48.62 | 51.60 | 63.01 |
| Dividend Payout % | 12% | 11% | 9% | 7% | 8% | 10% | 5% | 5% | 10% | 17% | 23% | 21% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 2% |
| 3 Years: | -15% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -7% |
| 3 Years: | -20% |
| TTM: | 34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | -14% |
| 3 Years: | -1% |
| 1 Year: | 46% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | 10% |
| Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 221 | 274 | 356 | 461 | 568 | 652 | 888 | 1,243 | 1,548 | 1,715 | 1,839 | 1,970 |
| 256 | 173 | 105 | 152 | 227 | 260 | 127 | 101 | 58 | 20 | 11 | 133 | |
| 139 | 152 | 168 | 229 | 244 | 195 | 289 | 395 | 351 | 405 | 396 | 633 | |
| Total Liabilities | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,745 | 1,963 | 2,146 | 2,252 | 2,743 |
| 341 | 341 | 325 | 316 | 320 | 573 | 543 | 681 | 780 | 896 | 1,003 | 1,043 | |
| CWIP | 3 | 16 | 25 | 123 | 269 | 46 | 173 | 141 | 113 | 205 | 238 | 512 |
| Investments | 0 | 0 | 0 | 0 | 0 | 48 | 0 | 0 | 73 | 0 | 0 | 0 |
| 278 | 248 | 284 | 409 | 457 | 446 | 594 | 923 | 996 | 1,046 | 1,011 | 1,188 | |
| Total Assets | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,745 | 1,963 | 2,146 | 2,252 | 2,743 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 85 | 60 | 140 | 94 | 144 | 110 | 220 | 354 | 334 | 255 | 184 | |
| -4 | -29 | -10 | -135 | -119 | -130 | -62 | -147 | -210 | -274 | -139 | -344 | |
| -55 | -54 | -55 | 16 | 21 | -26 | -37 | -57 | -81 | -75 | -49 | 85 | |
| Net Cash Flow | -3 | 2 | -5 | 21 | -4 | -12 | 11 | 16 | 63 | -15 | 68 | -75 |
| Free Cash Flow | 48 | 53 | 47 | 32 | -75 | 83 | -21 | 72 | 234 | 82 | 69 | -186 |
| CFO/OP | 65% | 77% | 58% | 101% | 74% | 108% | 40% | 56% | 81% | 123% | 128% | 82% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 71 | 68 | 73 | 65 | 81 | 85 | 93 | 59 | 71 | 72 | 89 |
| Inventory Days | 114 | 80 | 106 | 70 | 116 | 77 | 64 | 66 | 89 | 116 | 128 | 113 |
| Days Payable | 48 | 58 | 55 | 56 | 60 | 42 | 44 | 54 | 18 | 31 | 32 | 39 |
| Cash Conversion Cycle | 136 | 93 | 119 | 87 | 120 | 116 | 104 | 105 | 129 | 156 | 168 | 163 |
| Working Capital Days | 7 | 12 | 42 | 31 | 47 | 55 | 88 | 88 | 89 | 114 | 120 | 69 |
| ROCE % | 18% | 23% | 30% | 32% | 24% | 18% | 35% | 49% | 36% | 17% | 11% | 11% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Export Revenue Share % ・Standalone data |
|
||||||
| Installed Capacity MTPA ・Standalone data |
|||||||
| Hotel Occupancy Rate % ・Standalone data |
|||||||
| Hotel RevPAR Rs ・Standalone data |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
- Ind-Ra withdrew Balaji Amines’ rating for ₹1,950 million bank loan facilities on 11 September 2026.
-
Announcement under Regulation 30 (LODR)-Credit Rating
- Ind-Ra withdrew Balaji Amines' bank loan rating on 12 September 2026 after all dues were cleared.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement Regarding Specials Window for Transfer and Dematerialisation of Physical Shares
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Balaji Amines schedules analyst/investor plant visit in Solapur on 25 August 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Balaji Amines to host virtual analyst and investor group meeting on 21 August 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
Jul 2026PPT
-
May 2026Transcript PPT REC
-
Jan 2026PPT
-
Nov 2025Transcript PPT
-
Aug 2025PPT
-
Jun 2025Transcript PPT
-
Feb 2025PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024PPT
-
May 2024Transcript
-
May 2024Transcript PPT
-
Feb 2024PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023PPT
-
Oct 2022PPT
-
Aug 2022PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Jan 2020PPT
-
Dec 2019Transcript PPT
-
Nov 2019PPT
-
Aug 2019Transcript PPT
-
Jul 2019PPT
-
May 2019Transcript
-
Aug 2018Transcript
-
May 2018Transcript
-
Feb 2018Transcript
-
Feb 2017Transcript
-
Feb 2017Transcript
Market Leadership[1]
The Company is the largest manufacturer of aliphatic amines and methylamines in India, the only domestic company to develop indigenous amines manufacturing technology, and the sole Indian producer of several specialty chemicals